Navigation Links
New Combination Locking Cap Designed to Protect Children and Teens From Prescription Medications
Date:9/26/2011

LINCOLN, Calif., Sept. 26, 2011 /PRNewswire/ -- Safely storing prescription medications has always been a challenge for parents and other prescription holders. Now, an innovative new device allows prescription holders to safely secure and store dangerous medications—in a small, convenient and more portable container.

(Photo: http://photos.prnewswire.com/prnh/20110926/SF75139)

Developed by CAP-N-LOCK, LLC., The Locking Cap is a combination locking cap designed to work with existing prescription medication bottles. The Locking Cap was designed to help families prevent unauthorized and undetected use of prescription medications for non-medical purposes. With a four-digit combination locking mechanism and sturdy PVC construction, it is easy to use, but virtually impossible to get past without detection.

"The Locking Cap eliminates unauthorized access to dangerous prescription drugs," said Joseph Simpson, President and product designer for CAP-N-LOCK. "The Locking Cap is very easy to operate. It protects families by blocking access to curious children and experimental teens. Plus, it features a compact design that allows for easy access and storage when traveling and at home."

The Locking Cap is designed and manufactured in the United States and is currently available in national pharmacies and online at http://www.TheLockingCap.com

About CAP-N-LOCK, LLC.

CAP-N-LOCK specializes in family safety product design, development, manufacturing and marketing. The non-medical use and abuse of prescription drugs is a serious and growing public health problem in the U.S. and is rapidly becoming a global epidemic. The majority of people use prescription medications responsibly; however, an estimated 48 million people in the U.S. (ages 12 and older) have used prescription drugs for non-medical reasons. The Locking Cap was created to protect families and help prevent prescription drug abuse and overdoses. For more information about The Locking Cap, visit http://www.TheLockingCap.com or call (408) 206-0120.  

Available at Ralphs, SaveMart, and Lucky Pharmacies.

Contact:
Deborah Simpson, Chairman & CEO, CAP-N-LOCK, LLC., at (408) 206-0120 or dsimpson@TheLockingCap.com


'/>"/>
SOURCE CAP-N-LOCK, LLC.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pearl Therapeutics Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva®
2. SANYO Adds New MPR Series Biomedical Refrigerator/Freezer Combination Unit
3. Specialty Silicone Fabricators Adds Analytical Laboratory to Bolster Combination Product Services
4. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
5. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
6. Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed-Dose Combination of PREZISTA® and Cobicistat
7. Launch of Nuromol a New Painkiller Combination
8. ReportsnReports - Multitargeted Therapies: Promiscuous Drugs and Combination Therapies
9. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
10. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
11. All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Kalifornien, 12. Februar 2016  Sequent ... der Aufnahme von Patienten für eine Studie zur ... Aneurysmen („WEB") speziell für die Behandlung von rupturierten ... , MD, Leiter der Neuroradiologie an der Universitätsklinik ... und Hauptprüfarzt der CLARYS-Studie hat den ersten Patienten ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
(Date:2/12/2016)... BUDAPEST , Ungarn, February 12, 2016 ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ... gab heute positive Ergebnisse seines klinischen Forschungsprogramms ... und Asthma-Patienten beschäftigt, ergab Verbesserungen ihrer respiratorischen ... Indiso ltd , ein Medizintechnikunternehmen, das ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... ... DDi , a Makro company, makes it to ... in eClinical Solutions. DDi has built its solution competency with a unique blend ... DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by providing ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... over 250 members of South Florida’s philanthropic community at its 10th anniversary Fashion ...
(Date:2/12/2016)... ... 2016 , ... Coco Libre, the maker of coconut water beverages with a ... Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut ... invitation-only gifting suite, held this year at the W Hollywood Hotel, has become a ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman ... John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, ... VA Southern Nevada Healthcare System. This will be the first Fisher House in ...
(Date:2/12/2016)... ... February 12, 2016 , ... Young ... area, celebrates the beginning of the latest charity campaign in their community enrichment ... art. Donations to this worthy cause are currently being accepted at: http://artexpressioninc.org/ ...
Breaking Medicine News(10 mins):